HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Hemant Menghani Selected Research
Hemant Menghani Research Topics
Disease
2
Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome)
11/2020 - 01/2017
2
Infarction (Infarctions)
11/2020 - 01/2017
2
Stroke (Strokes)
11/2020 - 08/2018
2
Ischemic Stroke
08/2018 - 01/2017
1
Glioblastoma (Glioblastoma Multiforme)
01/2021
1
Inflammation (Inflammations)
01/2021
1
Neoplasms (Cancer)
01/2021
1
Ischemia
01/2017
Drug/Important Bio-Agent (IBA)
2
Docosahexaenoic Acids
IBA
11/2020 - 08/2018
1
Lipids
IBA
01/2021
1
LAU 0901
IBA
01/2021
1
Bevacizumab (Avastin)
FDA Link
01/2021
1
Ketamine
FDA Link
Generic
01/2021
1
Luciferases
IBA
01/2021
1
Xylazine (Xylazin)
IBA
01/2021
1
Cell Surface Receptors
IBA
11/2020
1
Proteins (Proteins, Gene)
FDA Link
11/2020
1
protectin D1
IBA
08/2018
1
Bromodeoxyuridine (BrdU)
IBA
08/2018
1
Sodium
IBA
01/2017
1
Esters
IBA
01/2017
1
Glucose (Dextrose)
FDA Link
Generic
01/2017
1
Oxygen (Dioxygen)
IBA
01/2017
1
Salts
IBA
01/2017
1
N-Methyl-D-Aspartate Receptors (NMDA Receptors)
IBA
01/2017
Therapy/Procedure
1
Therapeutics
01/2021